EpCAM is overexpressed in local and metastatic prostate cancer, suppressed by chemotherapy and modulated by MET-associated miRNA-200c/205

por Massoner, P, Thomm, T, Mack, B, Untergasser, G, Martowicz, A, Bobowski, K, Klocker, H, Gires, O, Puhr, M
Publicado 2014